永嘉集團(03322.HK)擬3980萬港元出售城勝全部股權
格隆匯1月28日丨永嘉集團(03322.HK)發佈公吿,於2022年1月28日,公司(作為賣方)與買方Huge Castle Limited訂立買賣協議,公司有條件同意出售目標公司城勝有限公司全部已發行股本;及向買方出讓而買方有條件同意向公司收購待售貸款,總代價為3980萬港元。
目標公司為在香港註冊成立的有限公司,為公司的全資附屬公司,主要於香港從事物業持有。
該物業目前用作集團的倉庫。董事會認為,監於該物業目前並未充分使用,出售事項為變現該物業價值的良機,而出售事項的所得款項淨額將改善集團的財務狀況。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.